2026-09-01 04:00 UTCOriginal source3 min readUpdated: 2026-09-01 09:05 UTC

A collective capability boundary in frontier large language models on guideline-conformant and case-specific oncology decision-making

arXiv:2608.28592v1 Announce Type: new Abstract: Large language models (LLMs) achieve high scores on medical knowledge examinations, yet real-world oncology is not a knowledge test--it is a sequence of guideline-pathway choices, escalation judgments, and commitments under uncertainty. Existing benchmarks largely measure factual recall, leaving open whether frontier LLMs share decision-path blind spots that combining models cannot fix. We built the Oncology Decision Boundary Benchmark (ODBB)--2,005 oncology decision points across NCCN guidelines and colorectal cancer cases--and evaluated nine frontier LLMs (four closed-source, five open-weight families) released between June 2025 and April 2026. A fully deterministic scorer (zero LLM inference) classified outputs into 14 failure types, independently validated by two oncologists (Cohen's weighted $\kappa$ = 0.939 and 0.790) on a 225-item stratified sample. Treating the nine as a pooled super-model, 42.1% (Wilson 95% CI 40.0--44.3%) of all items--35.7% of the 1,586 NCCN items and 66.4% of the 419 colorectal-cancer cases--were answered correctly by none, with failures concentrated in choosing between guideline pathways before reasoning within any: a consistent blind spot in clinical meta-judgment that likely requires architectural intervention rather than more training data. Two models tuned for decisiveness (GPT-5.5, Gemini 3.1 Pro Preview) made unsafe commitments three to five times more often than the seven cautious models without scoring higher. In 3--9% of items, models stated the correct next clinical step yet did not commit to it--failures of decision, not knowledge. Model quality is no longer the primary bottleneck for clinical LLM deployment; the binding constraint is the assumption that any single model can be the sole basis for a clinical decision. Progress requires architectures that detect when a model reaches its competence boundary and route the decision to a clinician.

SourcearXiv AIAuthor: Zhang Sheng, Jinming Li, Wangyang Chen, Zhiwei Bao, Yu YoSean Wang

-->

[Submitted on 8 Jun 2026]

Title:A collective capability boundary in frontier large language models on guideline-conformant and case-specific oncology decision-making

View a PDF of the paper titled A collective capability boundary in frontier large language models on guideline-conformant and case-specific oncology decision-making, by Zhang Sheng and 4 other authors

View PDF HTML (experimental)

Abstract:Large language models (LLMs) achieve high scores on medical knowledge examinations, yet real-world oncology is not a knowledge test--it is a sequence of guideline-pathway choices, escalation judgments, and commitments under uncertainty. Existing benchmarks largely measure factual recall, leaving open whether frontier LLMs share decision-path blind spots that combining models cannot fix. We built the Oncology Decision Boundary Benchmark (ODBB)--2,005 oncology decision points across NCCN guidelines and colorectal cancer cases--and evaluated nine frontier LLMs (four closed-source, five open-weight families) released between June 2025 and April 2026. A fully deterministic scorer (zero LLM inference) classified outputs into 14 failure types, independently validated by two oncologists (Cohen's weighted $\kappa$ = 0.939 and 0.790) on a 225-item stratified sample. Treating the nine as a pooled super-model, 42.1% (Wilson 95% CI 40.0--44.3%) of all items--35.7% of the 1,586 NCCN items and 66.4% of the 419 colorectal-cancer cases--were answered correctly by none, with failures concentrated in choosing between guideline pathways before reasoning within any: a consistent blind spot in clinical meta-judgment that likely requires architectural intervention rather than more training data. Two models tuned for decisiveness (GPT-5.5, Gemini 3.1 Pro Preview) made unsafe commitments three to five times more often than the seven cautious models without scoring higher. In 3--9% of items, models stated the correct next clinical step yet did not commit to it--failures of decision, not knowledge. Model quality is no longer the primary bottleneck for clinical LLM deployment; the binding constraint is the assumption that any single model can be the sole basis for a clinical decision. Progress requires architectures that detect when a model reaches its competence boundary and route the decision to a clinician.

Subjects:

Artificial Intelligence (cs.AI)

Cite as: arXiv:2608.28592 [cs.AI]

(or arXiv:2608.28592v1 [cs.AI] for this version)

https://doi.org/10.48550/arXiv.2608.28592

arXiv-issued DOI via DataCite

Submission history

From: Zhang Sheng [view email] [v1] Mon, 8 Jun 2026 02:24:59 UTC (23,153 KB)

Full-text links:

Access Paper:

View PDF

HTML (experimental)

TeX Source

view license

Current browse context:

cs.AI

new | recent | 2026-08

Change to browse by:

References & Citations

NASA ADS

Google Scholar

Semantic Scholar

Data provided by:

Bibliographic Tools

Bibliographic and Citation Tools

Bibliographic Explorer Toggle

Bibliographic Explorer (What is the Explorer?)

Connected Papers Toggle

Connected Papers (What is Connected Papers?)

Litmaps Toggle

Litmaps (What is Litmaps?)

scite.ai Toggle

scite Smart Citations (What are Smart Citations?)

Code, Data, Media

Code, Data and Media Associated with this Article

alphaXiv Toggle

alphaXiv (What is alphaXiv?)

Links to Code Toggle

CatalyzeX Code Finder for Papers (What is CatalyzeX?)

DagsHub Toggle

DagsHub (What is DagsHub?)

GotitPub Toggle

Gotit.pub (What is GotitPub?)

Huggingface Toggle

Hugging Face (What is Huggingface?)

ScienceCast Toggle

ScienceCast (What is ScienceCast?)

Demos

Replicate Toggle

Replicate (What is Replicate?)

Spaces Toggle

Hugging Face Spaces (What is Spaces?)

Spaces Toggle

TXYZ.AI (What is TXYZ.AI?)